RSSDI Drug Series Thiazolidinedione

RSSDI Drug Series Thiazolidinedione

₹995.00

-
+
Secure Checkout

100% Secure Payments

Fast & Reliable Shipping

Worldwide Delivery

Easy Returns

Hassle Free

Description

This comprehensive medical textbook provides an in-depth understanding of thiazolidinediones (TZDs), also known as glitazones, an important class of oral antidiabetic agents used in the management of type 2 diabetes mellitus. The book explores the mechanisms of action, clinical applications, therapeutic benefits, and evolving role of TZDs in diabetes care. It places particular emphasis on insulin resistance, a key pathogenic factor in type 2 diabetes, while presenting current mechanistic insights and clinical evidence in an accessible manner. Designed for physicians, postgraduate students, researchers, and healthcare professionals, this resource offers a balanced perspective combining scientific understanding, clinical trial data, and real-world considerations. It is a useful reference for readers seeking to strengthen their knowledge of TZDs and their place in contemporary diabetes management.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Editorial Team

Anuj Maheshwari

MD FICP FIACM FIMSA FRSSDI FACP (USA) FACE (USA) FRCP (London, Edinburgh)
Professor
Department of Medicine
Hind Institute of Medical Sciences
Lucknow, Uttar Pradesh, India

Vijay Viswanathan

MD PhD FRCP (London, Glasgow)
National President, RSSDI
Head and Chief Physician
Department of Diabetology
MV Diabetes
Chennai, Tamil Nadu, India

Sanjay Agarwal

MD FACE FACP
Director, Department of Diabetes, Obesity and Metabolic Diseases, Ruby Hall
Head, Department of Diabetes, Obesity and Metabolic Diseases, Sahyadri Hospitals
Pune, Maharashtra, India

Rakesh Sahay

MD DNB DM (Endocrinology) FICP FACE
Immediate Past President, RSSDI
Past President, Endocrine Society of India
Professor
Department of Endocrinology
Osmania Medical College
Hyderabad, Telangana, India